FDA WARNING_LETTER - SALAZAR & SONS CORP - August 26, 2022

FDA WARNING_LETTER for SALAZAR & SONS CORP on August 26, 2022. Product: Food. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for SALAZAR & SONS CORP on August 26, 2022. Product: Food. Access full analysis and detailed observations.

Violation Codes

21 U.S.C. 350h

21 U.S.C. 384a

21 CFR 112.3

21 CFR 112

21 U.S.C. 381(a)(3)

21 CFR 1

21 U.S.C. 331(zz)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

SALAZAR & SONS CORP

Inspection Date

August 26, 2022

Product Type

Food

Office

Division of Southwest Imports

People

Todd W. Cato (Program Division Director)

ID: a0c81300-d62f-427f-9098-774faab2b28d

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox